BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1279672)

  • 21. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
    Burton DR; Barbas CF; Persson MA; Koenig S; Chanock RM; Lerner RA
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10134-7. PubMed ID: 1719545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitope specificities of human serum antibodies reactive with respiratory syncytial virus fusion protein.
    Robinson BS; Everson JS
    Arch Virol; 1992; 125(1-4):273-86. PubMed ID: 1379425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human monoclonal antibodies to human cytomegalovirus glycoprotein B neutralize virus in a complement-dependent manner.
    Ohta A; Fujita A; Murayama T; Iba Y; Kurosawa Y; Yoshikawa T; Asano Y
    Microbes Infect; 2009 Nov; 11(13):1029-36. PubMed ID: 19651232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.
    Trudel M; Stott EJ; Taylor G; Oth D; Mercier G; Nadon F; Séguin C; Simard C; Lacroix M
    Arch Virol; 1991; 117(1-2):59-71. PubMed ID: 1706591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization.
    Wu H; Pfarr DS; Tang Y; An LL; Patel NK; Watkins JD; Huse WD; Kiener PA; Young JF
    J Mol Biol; 2005 Jul; 350(1):126-44. PubMed ID: 15907931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.
    Williams JV; Chen Z; Cseke G; Wright DW; Keefer CJ; Tollefson SJ; Hessell A; Podsiad A; Shepherd BE; Sanna PP; Burton DR; Crowe JE; Williamson RA
    J Virol; 2007 Aug; 81(15):8315-24. PubMed ID: 17522220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein.
    Xie Q; Wang Z; Ni F; Chen X; Ma J; Patel N; Lu H; Liu Y; Tian JH; Flyer D; Massare MJ; Ellingsworth L; Glenn G; Smith G; Wang Q
    PLoS One; 2019; 14(2):e0210749. PubMed ID: 30730999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies.
    Anderson LJ; Bingham P; Hierholzer JC
    J Virol; 1988 Nov; 62(11):4232-8. PubMed ID: 2459412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
    Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning, expression and functional activities of a single chain antibody fragment directed to fusion protein of respiratory syncytial virus.
    Guirakhoo F; Catalan J; Monath T; Weltzin R
    Immunotechnology; 1996 Sep; 2(3):219-28. PubMed ID: 9373314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library.
    Gram H; Marconi LA; Barbas CF; Collet TA; Lerner RA; Kang AS
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3576-80. PubMed ID: 1565653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus.
    López JA; Peñas C; García-Barreno B; Melero JA; Portela A
    J Virol; 1990 Feb; 64(2):927-30. PubMed ID: 1688629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response.
    Akerlind-Stopner B; Utter G; Norrby E; Mufson MA
    J Med Virol; 1995 Oct; 47(2):120-5. PubMed ID: 8830114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9.
    Johnson S; Griego SD; Pfarr DS; Doyle ML; Woods R; Carlin D; Prince GA; Koenig S; Young JF; Dillon SB
    J Infect Dis; 1999 Jul; 180(1):35-40. PubMed ID: 10353858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human monoclonal Fab fragments from a combinatorial library prepared from an individual with a low serum titer to a virus.
    Bender E; Pilkington GR; Burton DR
    Hum Antibodies Hybridomas; 1994; 5(1-2):3-8. PubMed ID: 7858180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.
    Olmsted RA; Elango N; Prince GA; Murphy BR; Johnson PR; Moss B; Chanock RM; Collins PL
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7462-6. PubMed ID: 3532115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies.
    Palomo C; Albar JP; García-Barreno B; Melero JA
    J Virol; 1990 Sep; 64(9):4199-206. PubMed ID: 2384917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.